---
figid: PMC9428632__fphar-13-950886-g004
figtitle: Roles of glycolysis in osteosarcoma
organisms:
- herbal medicine
- Arachis hypogaea
- Salvia miltiorrhiza
- Punica granatum
- Ustilago maydis
- Sophora flavescens
- Epimedium koreanum
- Selaginella tamariscina
- Mus musculus
- Rattus norvegicus
- Human gammaherpesvirus 8
- Vesicular stomatitis virus
- Homo sapiens
- NA
pmcid: PMC9428632
filename: fphar-13-950886-g004.jpg
figlink: /pmc/articles/PMC9428632/figure/F4/
number: F4
caption: Signal pathways, transcription factors and ncRNAs that regulate glycolysis
  in osteosarcoma. The enhancement of glycolysis in osteosarcoma promotes the malignant
  behaviors such as proliferation, metastasis and drug resistance of osteosarcoma
  cells. Most miRNAs inhibit the progression of osteosarcoma by inhibiting glycolysis,
  with the exception of miR-21-5p and miR-522-3p. Most lncRNAs promotes the progression
  of osteosarcoma by promoting glycolysis, with the exception of lncRNA-SARCC and
  lncRNAHAND2-AS1. All circRNAs promote osteosarcoma progression by promoting glycolysis.
  Transcription factors c-myc and HIF-1α promote glycolysis and osteosarcoma progression.
  Signal pathways PI3K/AKT, AKT/mTOR, NF-κB, TGF-β, EGFR, Wnt/β-catenin, Wnt5a/Ror2
  promote glycolysis pathway and osteosarcoma progression.
papertitle: The roles of glycolysis in osteosarcoma.
reftext: Zuxi Feng, et al. Front Pharmacol. 2022;13:950886.
year: '2022'
doi: 10.3389/fphar.2022.950886
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: osteosarcoma | glycolysis | signaling pathway | Cancer Progression | key
  enzymes
automl_pathway: 0.9157753
figid_alias: PMC9428632__F4
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
redirect_from: /figures/PMC9428632__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9428632__fphar-13-950886-g004.html
  '@type': Dataset
  description: Signal pathways, transcription factors and ncRNAs that regulate glycolysis
    in osteosarcoma. The enhancement of glycolysis in osteosarcoma promotes the malignant
    behaviors such as proliferation, metastasis and drug resistance of osteosarcoma
    cells. Most miRNAs inhibit the progression of osteosarcoma by inhibiting glycolysis,
    with the exception of miR-21-5p and miR-522-3p. Most lncRNAs promotes the progression
    of osteosarcoma by promoting glycolysis, with the exception of lncRNA-SARCC and
    lncRNAHAND2-AS1. All circRNAs promote osteosarcoma progression by promoting glycolysis.
    Transcription factors c-myc and HIF-1α promote glycolysis and osteosarcoma progression.
    Signal pathways PI3K/AKT, AKT/mTOR, NF-κB, TGF-β, EGFR, Wnt/β-catenin, Wnt5a/Ror2
    promote glycolysis pathway and osteosarcoma progression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HAND2-AS1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - ROR2
  - RORA
  - SETD2
  - MYC
  - EGFR
  - TGFB1
  - TGFB2
  - TGFB3
  - NFKB1
  - MTOR
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - Hand2os1
  - Ror2
  - Rora
  - Wnt5a
  - Myc
  - Nol3
  - Egfr
  - Tgfb1
  - Ltbp1
  - Nfkb1
  - Mtor
  - Akt1
  - Pik3r1
  - Wnt2
  - Pik3cg
---
